Literature DB >> 16698915

Evaluation of the antibacterial activity and toxicity of 2 new hydrogels: a pilot study.

Katia Vandenbulcke1, Lada-Ivana Laenen Horvat, Martine De Mil, Guido Slegers, Hilde Beele.   

Abstract

Wound bed preparation remains a very important issue in wound healing. To promote the production of granulation tissue, it is necessary to remove necrotic tissue and to control infection. Necrotic tissue may be removed using a hydrogel preparation. Flaminal and Flaminal Hydro (Flen Pharma, Belgium) are 2 new hydroactive colloid gel dressings with state antibacterial properties. These properties are attributed to an enzymatic complex in their formulation. In the study described in this report, the antibacterial effects of Flaminal and Flaminal Hydro were confirmed in an in vitro as well as an in vivo setting. It was also demonstrated that Flaminal and Flaminal Hydro are not toxic to keratinocytes in vitro using an MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] test.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16698915     DOI: 10.1177/1534734606289507

Source DB:  PubMed          Journal:  Int J Low Extrem Wounds        ISSN: 1534-7346            Impact factor:   2.057


  5 in total

Review 1.  [Wound management with enzyme alginogels : Expert consensus].

Authors:  R Strohal; B Assenheimer; M Augustin; G Hämmerle; S Läuchli; B Pundt; G Stern; M Storck; C Ulrich
Journal:  Hautarzt       Date:  2017-01       Impact factor: 0.751

2.  The inhibition of Staphylococcus epidermidis biofilm formation by vancomycin-modified titanium alloy and implications for the treatment of periprosthetic infection.

Authors:  Valentin Antoci; Christopher S Adams; Javad Parvizi; Helen M Davidson; Russell J Composto; Theresa A Freeman; Eric Wickstrom; Paul Ducheyne; Donald Jungkind; Irving M Shapiro; Noreen J Hickok
Journal:  Biomaterials       Date:  2008-09-23       Impact factor: 12.479

3.  Inhibition of biofilms by glucose oxidase, lactoperoxidase and guaiacol: the active antibacterial component in an enzyme alginogel.

Authors:  Rose A Cooper
Journal:  Int Wound J       Date:  2013-05-15       Impact factor: 3.315

4.  Flaminal® versus Flamazine® in the treatment of partial thickness burns: A randomized controlled trial on clinical effectiveness and scar quality (FLAM study).

Authors:  Zjir M Rashaan; Pieta Krijnen; Kelly A A Kwa; Cornelis H van der Vlies; Inger B Schipper; Roelf S Breederveld
Journal:  Wound Repair Regen       Date:  2019-02-11       Impact factor: 3.617

5.  Clinical effectiveness, quality of life and cost-effectiveness of Flaminal® versus Flamazine® in the treatment of partial thickness burns: study protocol for a randomized controlled trial.

Authors:  Zjir M Rashaan; Pieta Krijnen; M Elske van den Akker-van Marle; Margriet E van Baar; Adrianus F P Vloemans; Jan Dokter; Fenike R H Tempelman; Cees H van der Vlies; Roelf S Breederveld
Journal:  Trials       Date:  2016-03-05       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.